Abstract
Much interest has focused on the newer incretin-based therapeutic modalities for diabetes, especially GLP-1 analogues. While the comparatively older GLP-1 analogs, exenatide and liraglutide, have been discussed extensively in literature, much less is known about the newer GLP-1 analogues in the pipeline. This review focuses on the newer molecules being studied, the newer routes of administration being tried, some recent patents and potential uses for these multifaceted compounds.
Keywords: GLP-1 analogs, long acting exenatide, albiglutide, taspoglutide, GLP-2 analogs, GLP-1 secretagogues
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: GLP - 1 Analogs: Newer Molecules, Newer Uses
Volume: 3 Issue: 2
Author(s): Sanjay Kalra, Bharti Kalra and Amit Kumar
Affiliation:
Keywords: GLP-1 analogs, long acting exenatide, albiglutide, taspoglutide, GLP-2 analogs, GLP-1 secretagogues
Abstract: Much interest has focused on the newer incretin-based therapeutic modalities for diabetes, especially GLP-1 analogues. While the comparatively older GLP-1 analogs, exenatide and liraglutide, have been discussed extensively in literature, much less is known about the newer GLP-1 analogues in the pipeline. This review focuses on the newer molecules being studied, the newer routes of administration being tried, some recent patents and potential uses for these multifaceted compounds.
Export Options
About this article
Cite this article as:
Kalra Sanjay, Kalra Bharti and Kumar Amit, GLP - 1 Analogs: Newer Molecules, Newer Uses, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2009; 3 (2) . https://dx.doi.org/10.2174/187221409788452309
DOI https://dx.doi.org/10.2174/187221409788452309 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Why Multiples of 21? Why does Selenoprotein P Contain Multiple Selenocysteine Residues?
Current Nutraceuticals Frontotemporal Lobar Degeneration (FTLD): Review and Update for Clinical Neurologists
Current Alzheimer Research Heart Failure in North America
Current Cardiology Reviews Regulatory Mechanisms of Calcineurin Phosphatase Activity
Current Medicinal Chemistry Cardiovascular Disease in Patients with Diabetic Nephropathy
Current Molecular Medicine Cardiac Specific Overexpression of hHole Attenuates Isoproterenol–Induced Hypertrophic Remodeling through Inhibition of Extracellular Signal-Regulated Kinases (ERKs) Signalling
Current Molecular Medicine Modulation of the Rho/ROCK Pathway in Heart and Lung after Thorax Irradiation Reveals Targets to Improve Normal Tissue Toxicity
Current Drug Targets Cardio-Vascular Risks Associated with Clozapine Treatment
Current Psychiatry Reviews Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Metabolomics and Heart Diseases: From Basic to Clinical Approach
Current Medicinal Chemistry Gender Differences in Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery Potential Application of Non-flavonoid Phenolics in Diabetes: Antiinflammatory Effects
Current Medicinal Chemistry Resurgence of Herbal Antihypertensives in Management of Hypertension
Current Hypertension Reviews Autophagy: For Better or for Worse, in Good Times or in Bad Times …
Current Molecular Medicine Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications
Current Pharmaceutical Design Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Endogenous Cardiotonics: Search and Problems
Cardiovascular & Hematological Disorders-Drug Targets Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction
Drug Design Reviews - Online (Discontinued) The Diagnostic and Prognostic Value of Brain Natriuretic Peptide and Aminoterminal (nt)-pro Brain Natriuretic Peptide
Current Pharmaceutical Design